About the Session
Moderated by J. Jacques Carter, MD, MPH, Assistant Professor, Harvard Medical School
The State of the Black Prostate Cancer Disparity Annual Address will provide an assessment of the progress, challenges, and opportunities impacting prostate health outcomes for Black/ African American men. During this session, PHEN will issue its inaugural State of Black Prostate Cancer Report Card, evaluating the nation’s progress in addressing the black prostate cancer disparity and identifying priorities for action in the years ahead. Attendees will gain valuable insights, hear a national call to action, and learn how they can help improve health outcomes and accountability across the healthcare ecosystem.
Session 1 Speakers
Agenda:
Watch Video Welcome and Introduction: Mr. Jerry Womack, PHEN Ambassador
Watch Video Moderator’s Welcome: J. Jacques Carter, MD, MPH, Assistant Professor, Harvard Medical School
Watch Video Remarks: Congressman Gregory Meeks, US House of Representatives, NY-5
Watch Video State of the Black Prostate Cancer Disparity Address: Thomas A. Farrington, President & Founder, PHEN
Watch Video Black Men’s Prostate Cancer Awareness Survey Results: Keith Crawford, MD, PhD, Director of Clinical Trials and Patient Education, PHEN Black Men’s Prostate Cancer Awareness Survey Results
Watch Video: Panel Response and Discussion:
- Leslie Deane, MD, FACS, MS, Professor and Chief of the Division of Urology, Howard University Hospital
- Diah Douglas, MD, Senior Medical Director, Oncology, Lantheus
- D’Anna Holmes, MSHA, CPXP, Associate Director, Patient Partnerships, Astellas Pharma
- Adam B. Murphy, MD, MBA, MSCI, Associate Professor, Feinberg School of Medicine, Northwestern Medical Group
- Yaw Nyame, MD, MS, MBA, Assistant Professor and OCOE Program Lead, Department of Urology, Fred Hutchinson Cancer Center, University of Washington
- Folakemi T. Odedina, Ph.D., BPharm, Director, Global Health Equity Initiatives, Center for Health Equity and Community Engagement Research, Mayo Clinic
- James Smith, MD, Patient Advocate and PHEN Ambassador
Audience Q&A
Closing Remarks and Survey: Mr. Thomas A. Farrington
THANK YOU TO OUR SPONSORS
